Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday

Published 03/10/2022, 08:24
Updated 03/10/2022, 09:10
© Reuters.  Why F45 Training  Shares Climbed 41%; Here Are 84 Biggest Movers From Friday

© Reuters. Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday

Gainers

  • FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
  • SAI.TECH Global Corporation (NASDAQ: SAI) gained 43.4% to close at $3.24 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
  • F45 Training Holdings Inc. (NYSE: FXLV) shares gained 41.1% to close at $3.09 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 39% to close at $10.08. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
  • SOBR Safe, Inc. (NASDAQ: SOBR) gained 38.9% to close at $2.68 after the company announced it signed three reseller agreements with national distributors.
  • Ainos, Inc. (NASDAQ: AIMD) shares jumped 37% to close at $1.89 on Friday after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
  • Alset EHome International Inc. (NASDAQ: AEI) climbed 30.9% to close at $0.2562.
  • O2Micro International Limited (NASDAQ: OIIM) gained 30.2% to close at $4.23 after the company announced it entered into a definitive agreement for a "going private" transaction.
  • PolarityTE, Inc. (NASDAQ: PTE) surged 27.9% to close at $0.87.
  • Pulse Biosciences, Inc. (NASDAQ: PLSE) gained 27.8% to close at $2.30. The FDA granted 510(k) clearance to the company’s CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III.
  • VectivBio Holding AG (NASDAQ: VECT) jumped 26.1% to close at $6.00.
  • Vincerx Pharma, Inc. (NASDAQ: VINC) surged 25.5% to close at $1.38.
  • Gracell Biotechnologies Inc. (NASDAQ: GRCL) gained 23.9% to settle at $3.22.
  • PLx Pharma Inc. (NASDAQ: PLXP) surged 23.7% to close at $0.65.
  • Waldencast plc (NASDAQ: WALD) rose 19.9% to close at $10.00.
  • Stabilis Solutions, Inc. (NASDAQ: SLNG) gained 19.3% to settle at $7.74.
  • Nemaura Medical Inc. (NASDAQ: NMRD) surged 18.9% to close at $2.08. Nemaura and EVERSANA recently signed a preliminary agreement for large-scale launch of Nemaura's diabetes management program in the US.
  • IGM Biosciences, Inc. (NASDAQ: IGMS) climbed 17% to close at $22.74.
  • FG Financial Group, Inc. (NASDAQ: FGF) gained 16.6% to settle at $FG Financial Group, Inc. (FGF).
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) climbed 14.9% to close at $6.59. InMed recently reported a FY22 net loss of $33.17 per share.
  • X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) gained 14.8% to close at $1.71. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
  • Akero Therapeutics, Inc. (NASDAQ: AKRO) rose 14.3% to close at $34.05. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) gained 13.7% to close at $15.96 after the company reported clinical updates from its Phase 1 Danon Disease Trial for RP-A501m which showed initial improvements across clinical, functional and biomarker endpoints. Evercore ISI raised its price target from $65 to $75.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) gained 13.5% to settle at $0.97.
  • Athersys, Inc. (NASDAQ: ATHX) gained 13.5% to close at $1.85. Athersys recently announced it entered into amended agreements to extend the exercise period of the warrants that were issued as part of a recent registered direct offering.
  • Snow Lake Resources Ltd. (NASDAQ: LITM) surged 12.8% to close at $1.76. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
  • Innovid Corp. (NYSE: CTV) gained 12% to settle at $2.71.
  • Quanterix Corporation (NASDAQ: QTRX) jumped 11.8% to close at $11.02.
  • MoneyLion Inc. (NYSE: ML) rose 11.1% to close at $0.8926. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
  • bluebird bio, Inc. (NASDAQ: BLUE) rose 11.1% to close at $6.33. bluebird bio recently named Katherine Breedis as interim CFO.
  • Benson Hill, Inc. (NYSE: BHIL) gained 10.9% to close at $2.74 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
  • Daseke, Inc. (NASDAQ: DSKE) climbed 10.6% to close at $5.41 after the company announced a $40 million stock repurchase program.
  • MINISO Group Holding Limited (NYSE: MNSO) surged 10.2% to close at $5.49. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
  • Poshmark, Inc. (NASDAQ: POSH) jumped 9.9% to close at $15.67.
  • Immuneering Corporation (NASDAQ: IMRX) gained 9.2% to close at $14.32. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
  • Iveda Solutions, Inc. (NASDAQ: IVDA) rose 6.6% to close at $0.65 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
  • IonQ, Inc. (NYSE: IONQ) gained 6.1% to close at $5.07 after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
  • Charles River Laboratories International, Inc. (NYSE: CRL) gained 3.6% to close at $196.80 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.

Losers

  • Atlis Motor Vehicles, Inc. (NASDAQ: AMV) dipped 39.9% to settle at $20.40 on Friday.
  • Aterian, Inc. (NASDAQ: ATER) fell 37.1% to close at $1.24 after the company priced a 10,526,368 share registered direct offering at $1.90 per share.
  • Edesa Biotech, Inc. (NASDAQ: EDSA) declined 34.7% to close at $0.9213. Edesa Biotech reported statistically significant mortality reductions in Phase 2 ARDS drug study.
  • American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT (LON:AVCT)) dropped 32.4% to close at $0.2016. AVCT announced intent to effect reverse stock split.
  • Antelope Enterprise Holdings Limited (NASDAQ: AEHL) shares fell 30.5% to close at $0.6256 on Friday after the company announced pricing of a $1 million registered direct offering.
  • FedNat Holding Company (NASDAQ: FNHC) dipped 27.6% to close at $0.1150.
  • 5E Advanced Materials Inc. (NASDAQ: FEAM) fell 27.6% to close at $10.16.
  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) dropped 24.7% to close at $0.2703 after the company priced a common stock offering of 20.1 million shares at $0.30 per share.
  • OpGen, Inc. (NASDAQ: OPGN) dipped 24% to close at $0.2862 after the company announced a $3.38 million registered direct offering.
  • Carnival Corporation (NYSE: NYSE:CCL) fell 23.3% to close at $7.03 after the company reported worse-than-expected Q3 EPS and sales results.
  • Kuke Music Holding Limited (NYSE: KUKE) dropped 22.3% to close at $0.4710. Kuke Music Holding filed for mixed shelf of up to $100 million.
  • Rent-A-Center Inc (NASDAQ: RCII) fell 21.6% to close at $17.51 as the company lowered its earnings guidance for the third quarter and named Mr. Fahmi Karam as new Executive Vice President - Chief Financial Officer.
  • SHF Holdings Inc (NASDAQ: SHFS) fell 20% to close at $6.99 after declining 15% on Thursday. Northern Lights Acquisition completed business combination of SHF, Safe Harbor Financial, which offers compliance services to financial institutions that serve the regulated cannabis industry.
  • COMSovereign Holding Corp. (NASDAQ: COMS) dropped 19.9% to close at $0.0768.
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) fell 19.4% to close at $0.4799.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 19.1% to close at $4.15. Ocular Therapeutix 10%+ owner Summer Road LLC reported purchase of 150,000 at an average price of $4.59 per share in Form 4 filing on Thursday.
  • Century Aluminum Company (NASDAQ: CENX) dipped 18.3% to close at $5.28 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
  • TH International Ltd (NASDAQ: THCH) declined 18% to close at $5.98.
  • Norwegian Cruise Line Holdings Ltd. (NASDAQ: NCLH) dropped 18% to close at $11.36 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
  • Terran Orbital Corporation (NYSE: LLAP) fell 17.7% to settle at $1.77.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) dipped 17.3% to close at $2.24.
  • Reading International, Inc. (NASDAQ: RDIB) fell 15.8% to close at $18.70.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) dropped 15.3% to close at $27.45.
  • Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares fell 15% to close at $13.95 after the company announced its REVERSE Phase 3 study of obeticholic acid did not meet its primary endpoint.
  • Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) dropped 14.8% to close at $1.61.
  • Mondee Holdings, Inc. (NASDAQ: MOND) fell 14.5% to close at $7.81.
  • Airspan Networks Holdings Inc. (NASDAQ: MIMO) dropped 14% to close at $2.02.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) fell 14% to close at $0.3614.
  • Royal Caribbean Cruises Ltd. (NYSE: RCL) fell 13.2% to close at $37.90 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) dropped 13.1% to close at $1.72.
  • NIKE, Inc. (NYSE: NKE) fell 12.8% to close at $83.12. NIKE reported better-than-expected earnings and sales results for its first quarter on Thursday. However, the company reported a rise in quarter-ended inventories and revenue in the Greater China region also declined from a year ago.
  • GigaCloud Technology Inc. (NASDAQ: GCT) dipped 11.8% to close at $10.11. GigaCloud Technology reported second-quarter FY22 sales growth of 11% year-on-year to $124 million.
  • Karat Packaging Inc. (NYSE: KRT) dropped 11.4% to close at $15.99.
  • Worthington Industries, Inc. (NYSE: WOR) declined 11.3% to settle at $38.14. BMO Capital maintained Worthington Industries with a Market Perform and lowered the price target from $58 to $52.
  • HilleVax, Inc. (NASDAQ: HLVX) fell 11.2% to close at $17.09.
  • Pintec Technology Holdings Limited (NASDAQ: PT) fell 11% to close at $0.27.
  • Under Armour, Inc. (NYSE: UAA) dipped 9.8% to settle at $6.65.
  • ContextLogic Inc. (NASDAQ: WISH) fell 9.6% to close at $0.7339.
  • Li-Cycle Holdings Corp. (NYSE: LICY) dropped 9.5% to close at $5.32. Morgan Stanley (NYSE:MS) maintained Li-Cycle Holdings with an Equal-Weight and lowered the price target from $8 to $7.
  • Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND) dropped 9.1% to close at $6.76.
  • Belpointe PREP, LLC (NYSE: OZ) dipped 9.1% to settle at $84.45.
  • AMTD Digital Inc. (NYSE: HKD) fell 8.2% to close at $46.80.
  • The Aaron's Company, Inc. (NYSE: AAN) dropped 7.5% to settle at $9.72.
  • DICK'S Sporting Goods, Inc. (NYSE: DKS) fell 7.4% to close at $104.64. Shares of retail and apparel companies at large traded lower in sympathy with Nike (NYSE:NKE), which fell after the company reported first-quarter financial results.
  • Lululemon Athletica Inc. (NASDAQ: NASDAQ:LULU) dipped 6.9% to close at $279.56 in sympathy with Nike, which fell after the company reported first-quarter financial results.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) fell 6.8% to close at $28.15 as the stock pulled back after gaining following FDA approval of RELYVRIO for ALS..
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.